Item 8.01 Other Items

As disclosed in its Annual Report on Form 10-K for the fiscal year ended June 30, 2008, on August 7, 2008, Cardinal Health, Inc. (the "Company") and the U.S. Drug Enforcement Administration ("DEA") staff reached an oral agreement in principle to resolve the suspension of licenses to distribute controlled substances held by three of the Company's distribution centers. On October 2, 2008, the Company entered into settlement agreements with the DEA and seven U.S. Attorneys' Offices that will result in reinstatement of the suspended licenses. Under the terms of the settlement agreement with the DEA, the Company agreed to, among other things, maintain a compliance program designed to detect and prevent diversion of controlled substances. As part of the settlement with the U.S. Attorneys' Offices, the Company will pay a settlement amount of $34 million, for which the Company had fully reserved in fiscal 2008.

-2-

---